WKHS Locations

Clinical Trials

Study Title

Maternal Blood Sample for Non-Invasive Determination of Fetal Chromosomal Abnormalities

Purpose

To develop a non-invasive (blood test) asay from maternal blood that will enable the detection of fetal chromosomal abnormalities.

Eligibility

At least 18 years or older
Single Pregnancy
Gestational age 8-20 weeks
Scheduled for an amniocentesis

Study Process

At least 18 years or older
Single Pregnancy
Gestational age 8-20 weeks
Scheduled for an amniocentesis

Trial Details

Principal Investigator:

Christian Briery, M.D.

IRB:

WIRB

IRB Number:

Trial Type:

Drug

Sponsor:

Sequenom

Contact Information:

Regional Perinatal Group
(318) 212-5860
Regionalperinatalgroup.com